Free press releases distribution network?

Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Thermo Fisher Scientific Unveils New Software Solution to Assess Zebrafish Toxicity at SOT 2009 - The Thermo Scientific Cellomics Arrayscan VTI HCS Reader and the ZebraTox v3.0 BioApplication enable High Content Imaging and Analysis on Zebrafish Embryos
Thermo Fisher Scientific Unveils New Software Solution to Assess Zebrafish Toxicity at SOT 2009

 

PRZOOM - /newswire/ - Baltimore, MD, United States, 2009/03/18 - The Thermo Scientific Cellomics Arrayscan VTI HCS Reader and the ZebraTox v3.0 BioApplication enable High Content Imaging and Analysis on Zebrafish Embryos.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Thermo Scientific Cellomics ZebraTox v3.0 BioApplication at the SOT 48th Annual Meeting and ToxExpo from March 15-19 2009. This unique technique, coupled with the best in class ArrayScan VTI system, provides a new solution that automates the imaging and quantitation of zebrafish (D. rerio) embryos after a toxic insult. This introduction not only strengthens the Thermo Fisher Scientific portfolio of leading-edge High Content products for toxicology applications, but more importantly provides a tool to measure the gross effects of compounds in this important model organism.

The new ZebraTox BioApplication assesses the size, shape and curvature of zebrafish embryos two or three days post fertilization and after a toxic insult. Configurable to use unlabelled or fluorescently labeled transgenic zebrafish embryos, the user can array the embryos in a 96 or 384 well format, then automatically image and quantitate features related to morphology, which are used to detect both gross and subtle changes in zebrafish development.

As a result of its ability to produce a high number of offspring along with its developmental and physiological similarity to mammals, the zebrafish embryo has become a widely-used model organism. Zebrafish promise to contribute to several aspects of the discovery process, including target identification, disease modeling, lead discovery and toxicity assessment by combining the scale and throughput of in vitro screens with the physiological complexity of in vivo animal studies, offering improved productivity for drug discovery, academic research and environmental toxicology studies.

This newly introduced ZebraTox BioApplication relies on the industry-leading Thermo Scientific Cellomics ArrayScan VTI system, which comprises HCS instrumentation, informatics and reagent products, allowing researchers to more rapidly test multiple compounds to discover potential effects on organism health and development. This application provides a unique, automated and less subjective, method for compound screening on organisms when compared to less sophisticated, traditional manual approaches.

The ZebraTox BioApplication, along with a selection of Thermo Scientific HCS products, can be seen at the Thermo Scientific booth #1663 at the Society of Toxiciology (SOT) Annual Meeting and ToxExpo, Baltimore, MD, March 15-19 2009.

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10.5 billion, we have more than 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike.

For further press information please contact: Eleanor CallanMonk, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom T: +44 1477 539 539 F: +44 1477 539 540 E: cellular[.]scottpr.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thermo Fisher Scientific Unveils New Software Solution to Assess Zebrafish Toxicity at SOT 2009

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Eleanor CallanMonk 
1-800-432-4091 mark.collins[.]thermofisher.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From The Scott Partnership / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  RightITnow Ltd

Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today